1. 24TiPKEYNOTE-756: A randomized, double-blind, phase III study of pembrolizumab or placebo with neoadjuvant chemotherapy and adjuvant endocrine therapy for high-risk, early-stage, ER+/HER2−breast cancer. (24th November 2019) Authors: Cardoso, F; Bardia, A; André, F; Cescon, D W; McArthur, H; Telli, M; Loi, S; Cortes, J; Schmid, P; Harbeck, N; Denkert, C; Jackisch, C; Jia, L; Hirshfield, K; Karantza, V Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 44OCCTG IND.231: A phase 1 trial evaluating CX-5461 in patients with advanced solid tumors. (5th March 2018) Authors: Hilton, J; Cescon, D W; Bedard, P; Ritter, H; Tu, D; Soong, J; Gelmon, K; Aparicio, S; Seymour, L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study. (26th November 2018) Authors: Adams, S; Schmid, P; Rugo, H S; Winer, E P; Loirat, D; Awada, A; Cescon, D W; Iwata, H; Campone, M; Nanda, R; Hui, R; Curigliano, G; Toppmeyer, D; O'Shaughnessy, J; Loi, S; Paluch-Shimon, S; Tan, A R; Card, D; Zhao, J; Karantza, V Journal: Annals of oncology Issue: Volume 30:Number 3(2019) Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study. (26th November 2018) Authors: Adams, S; Loi, S; Toppmeyer, D; Cescon, D W; De Laurentiis, M; Nanda, R; Winer, E P; Mukai, H; Tamura, K; Armstrong, A; Liu, M C; Iwata, H; Ryvo, L; Wimberger, P; Rugo, H S; Tan, A R; Jia, L; Ding, Y; Karantza, V; Schmid, P Journal: Annals of oncology Issue: Volume 30:Number 3(2019) Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗